Input your search keywords and press Enter.

Saudi Arabia launches comprehensive ‘Sehhaty’ app to facilitate obtaining Corona vaccine

Following the approval of the Saudi Food and Drug Authority to “register the Pfizer-Biotech vaccine for the Coronavirus in the Kingdom of Saudi Arabia after Pfizer submitted a request for approval for its registration, the Ministry of Health launched the “Sehhaty” app for citizens and residents to start registering and obtaining the Covid-19 vaccine.

The Sehhaty app aims to provide health services to individuals in the Kingdom of Saudi Arabia. It also allows the user to access health information and obtain several health services provided by various authorities in the health sector in the Kingdom.

These include services to update and follow up on vital checks, track dispensed medicines, review and share sick leave, develop a healthy lifestyle, and count steps through integration with the integrated health program in Apple HealthKit devices and other services related to individual and family health and health awareness.

Stages for getting the vaccine

The Ministry of Health has identified three stages, according to which the Corona vaccine will be distributed to citizens and residents through the Sehhaty app, indicating that there is a target group for each of these stages.

It explained that the first stage will target citizens and residents who are over 65 years old and those with occupations most vulnerable to infection, as well as people who are obese and have a body mass of over 40.

The first stage will also target those with immunodeficiencies such as organ transplantation or taking immunosuppressive drugs, and those with two or more of the following chronic diseases: asthma, diabetes, chronic kidney disease, chronic heart diseases including coronary artery disease and chronic obstructive pulmonary disease, and those with a history of a previous stroke.

The second phase targets citizens and residents who are over 50 years old, other health practitioners, and those with one of the following chronic diseases: asthma, diabetes, chronic kidney disease, chronic heart disease including coronary artery disease and chronic obstructive pulmonary disease, active cancer, and those with obesity whose body mass is between 30 and 40.

The third group targeted includes all citizens and residents who wish to receive the vaccine.

Sehhaty app

The Ministry of Health posted on Twitter to inform citizens about how to register on the Sehhaty app, commenting, “Register now through the Sehhaty application to take the Covid-19 Corona vaccine. The vaccine is safe and protects you and your loved ones from infection with the virus – God willing.”

It added that it is possible to register on the Sehhaty app via the following link: http://onelink.to/yjc3nj.

The registration steps for the Sehhaty app are as follows:

Download the application.

Sign in or create an account if you are a new member.

Choose “Covid-19 vaccine” to fill out the application form.

Determine the beneficiary of the vaccine.

Enter the required information in the application form.

Complete the application by clicking on the word “Next”.

The Sehhaty app has succeeded in attracting many people who want to get a Coronavirus vaccine, hours after the Saudi Ministry of Health announced the opening of registration. The number of registered individuals has reached more than 100,000 people, whether citizens or residents in the Kingdom of Saudi Arabia.

The Ministry of Health tweeted, “More than 100,000 people have registered so far in the Sehhaty application to receive the Corona vaccine (Covid-19).”

It is noteworthy that the Saudi Food and Drug Authority recently announced its approval of the registration for the Pfizer-Biotech vaccine after Pfizer applied for approval.

The authority said in a statement that “the decision to approve registering the vaccine and making it available for use was based on data submitted by Pfizer on November 24, to be the first vaccine approved by Saudi Arabia. After that, the health authorities in the Kingdom can import and use the vaccine.”